Want to join the conversation?
$AKAM 2Q15 PR: Cash from operations was $264MM, or 49% of revenue. Cash, cash equivalents & marketable securities as of June 30, 2015 was $1.5Bil. The Company spent $63MM to repurchase 0.9MM shares of its common stock at an average price of $74.12 per share. The Company had approx. 179MM shares of common stock outstanding as of June 30, 2015.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?